Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared a post on X:
“During the recent ASCO26 oncology meeting in Chicago and one day before the oral presentation, I had the opportunity to present the main findings of our study on intracranial efficacy of Tarlatamab in patients with small-cell lung cancer from the DeLLphi-304 trial in a video Interview with ASCO Post.
You can find the 5-minute video link here.
Thank you ASCO for highlighting our study!”
ASCO Living Guideline 2026.3.0 Updates Treatment Roadmap for Stage IV NSCLC With Driver Alterations
